What Are the Challenges in Biomarker Driven Therapies?
Despite the promise, biomarker driven therapies face several challenges:
Heterogeneity of Cancer: Tumors can be highly heterogeneous, with different cells exhibiting various biomarkers, complicating treatment. Resistance: Cancer cells can develop resistance to therapies, necessitating ongoing research and combination treatments. Cost and Accessibility: Advanced diagnostics and treatments can be expensive and not universally accessible.
